Primarily indicated for the treatment of epilepsy and seizures in adults and children. Used alone or in combination therapy, especially for partial seizures.

Common side effects may include dizziness, sleepiness, tiredness, headache, nausea, vomiting, stomach pain, diarrhea, constipation, and weakness. Most side effects are mild, but consult a healthcare provider if symptoms persist.

Consult a doctor before use, particularly if pregnant, planning pregnancy, or breastfeeding, as it may affect the baby. Monitor any unusual mood changes, including suicidal thoughts. Avoid abrupt discontinuation without medical advice to prevent rebound seizures.

Not recommended for individuals with known hypersensitivity to Oxcarbazepine.

As directed by the physician.

Available in various LATAM countries, including Paraguay, Peru, Suriname, Uruguay, and Venezuela, as well as Caribbean nations such as Cuba and the Dominican Republic.

Available in tablet and dispersible tablet forms for oral administration.

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai